Diabetic foot ulcers (DFUs) are a major clinical challenge, with high rates of morbidity, disability, amputations and ...

ORGO’s main drivers are its advanced wound-care and surgical biologics that leverage its evidence-rich portfolio. Click here ...

The Tissue Engineered Skin Substitute Market is projected to be worth USD 2.4 billion in 2024. The market is anticipated to reach USD 3.5 billion by 2034. The market is further expected to surge at a ...